» Articles » PMID: 23166590

Clinical Presentation of Atopic Dermatitis by Filaggrin Gene Mutation Status During the First 7 Years of Life in a Prospective Cohort Study

Overview
Journal PLoS One
Date 2012 Nov 21
PMID 23166590
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Filaggrin null mutations result in impaired skin barrier functions, increase the risk of early onset atopic dermatitis and lead to a more severe and chronic disease. We aimed to characterize the clinical presentation and course of atopic dermatitis associated with filaggrin mutations within the first 7 years of life.

Method: The COPSAC cohort is a prospective, clinical birth cohort study of 411 children born to mothers with a history of asthma followed during their first 7 years of life with scheduled visits every 6 months, as well as visits for acute exacerbations of dermatitis. Atopic dermatitis was defined in accordance with international guidelines and described at every visit using 35 predefined localizations and 10 different characteristics.

Results: A total of 170 (43%) of 397 Caucasian children developed atopic dermatitis. The R501X and/or 2282del4 filaggrin null mutations were present in 26 (15%) of children with atopic dermatitis and were primarily associated with predilection to exposed skin areas (especially the cheeks and back of the hands) and an up-regulation of both acute and chronic dermatitis. Furthermore, we found the filaggrin mutations to be associated with a higher number of unscheduled visits (3.6 vs. 2.7; p=0.04) and more severe (moderate-severe SCORAD 44% vs. 31%; p=0.14), and widespread dermatitis (10% vs. 6% of the body area, p<0.001) with an earlier age at onset (246 vs. 473 days, p<0.0001) compared to wild-type.

Conclusion: In children, filaggrin mutations seem to define a specific endotype of atopic dermatitis primarily characterized by predilection to exposed areas of the body, in particular hands and cheeks, and an up-regulation in both acute and chronic morphological markers. Secondary, this endotype is characterized by an early onset of dermatitis and a more severe course, with more generalized dermatitis resulting in more frequent medical consultations.

Citing Articles

Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches.

Afshari M, Kolackova M, Rosecka M, celakovska J, Krejsek J Front Immunol. 2024; 15:1361005.

PMID: 38500882 PMC: 10944924. DOI: 10.3389/fimmu.2024.1361005.


Classifying atopic dermatitis: a systematic review of phenotypes and associated characteristics.

Bosma A, Ascott A, Iskandar R, Farquhar K, Matthewman J, Langendam M J Eur Acad Dermatol Venereol. 2022; 36(6):807-819.

PMID: 35170821 PMC: 9307020. DOI: 10.1111/jdv.18008.


Cytokines and apoptosis in atopic dermatitis.

Szymanski U, Cios A, Ciepielak M, Stankiewicz W Postepy Dermatol Alergol. 2021; 38(2):1-13.

PMID: 34408560 PMC: 8362769. DOI: 10.5114/ada.2019.88394.


Clinical Characteristics and Genetic Variations in Early-Onset Atopic Dermatitis Patients.

Kim B, Wang H, Lee H, Lee S, Hong S, Choi E Ann Dermatol. 2021; 31(3):286-293.

PMID: 33911593 PMC: 7992730. DOI: 10.5021/ad.2019.31.3.286.


Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis.

Le Thanh Nguyen H, Trujillo-Paez J, Umehara Y, Yue H, Peng G, Kiatsurayanon C Int J Mol Sci. 2020; 21(20).

PMID: 33066696 PMC: 7589391. DOI: 10.3390/ijms21207607.


References
1.
Thyssen J, Carlsen B, Menne T, Linneberg A, Nielsen N, Meldgaard M . Filaggrin null mutations increase the risk and persistence of hand eczema in subjects with atopic dermatitis: results from a general population study. Br J Dermatol. 2010; 163(1):115-20. DOI: 10.1111/j.1365-2133.2010.09822.x. View

2.
Bisgaard H, Hermansen M, Buchvald F, Loland L, Halkjaer L, Bonnelykke K . Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007; 357(15):1487-95. DOI: 10.1056/NEJMoa052632. View

3.
Thyssen J, Carlsen B, Bisgaard H, Giwercman C, Johansen J, Linneberg A . Individuals who are homozygous for the 2282del4 and R501X filaggrin null mutations do not always develop dermatitis and complete long-term remission is possible. J Eur Acad Dermatol Venereol. 2011; 26(3):386-9. DOI: 10.1111/j.1468-3083.2011.04073.x. View

4.
Irvine A . Fleshing out filaggrin phenotypes. J Invest Dermatol. 2007; 127(3):504-7. DOI: 10.1038/sj.jid.5700695. View

5.
Simpson E, Thompson M, Hanifin J . Prevalence and morphology of hand eczema in patients with atopic dermatitis. Dermatitis. 2006; 17(3):123-7. DOI: 10.2310/6620.2006.06005. View